Breaking News Instant updates and real-time market news.

LZB

La-Z-Boy

$30.73

-1.14 (-3.58%)

15:42
08/20/19
08/20
15:42
08/20/19
15:42

La Z Boy options imply 11.9% move in share price post-earnings

Pre-earnings options volume in La Z Boy is 68.4x normal with puts leading calls 10:3. Implied volatility suggests the market is anticipating a move near 11.9%, or $3.65, after results are released. Median move over the past eight quarters is 10.7%.

  • 21

    Aug

  • 27

    Aug

LZB La-Z-Boy
$30.73

-1.14 (-3.58%)

08/23/18
08/23/18
DOWNGRADE

Sector Weight
La-Z-Boy downgraded to Sector Weight on valuation at KeyBanc
As previously reported, KeyBanc analyst Bradley Thomas downgraded La-Z-Boy to Sector Weight from Overweight on valuation. With the stock 20%-plus year over year and valuation elevated, the analyst believes the risk/reward for shares is more balanced on a six-month time frame. Thomas sees organic sales moderating from Q1, and incremental margin pressure in the quarters ahead. Lastly, while difficult to quantify, China tariffs could lead to downside to his current EPS estimates if exemptions are not made for the industry.
08/23/18
08/23/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Duluth Holdings (DLTH) downgraded to Neutral from Outperform at Baird. 2. La-Z-Boy (LZB) downgraded to Sector Weight from Overweight at KeyBanc with analyst Bradley Thomas citing valuation. 3. PermRock Royalty Trust (PRT) downgraded to Hold from Buy at Stifel with analyst Timothy Howard saying he believes significant long-term value remains in the trust, but cites "elevated" capital spending in the near term and "Permian differential uncertainty" for the downgrade. 4. ABM (ABM) downgraded to Neutral from Outperform at Baird with analyst Andrew Wittmann saying he sees the risk/reward as more balanced given near-term uncertainties and a possible risk to near-term guidance. 5. Coca-Cola Amatil (CCLAY) downgraded to Sell from Neutral at UBS and to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/17/18
SIDC
12/17/18
UPGRADE
Target $34
SIDC
Buy
La-Z-Boy upgraded to Buy from Neutral at Sidoti
Sidoti analyst Anthony Lebiedzinski upgraded La-Z-Boy to Buy from Neutral following a 34% decline in the shares since August. He believes the company is well-positioned to deal with tariffs compared to most peers and sees it product mix skewed to upholstery helping it continue to profitably increase revenue. Lebiedzinski keeps a $34 price target on La-Z-Boy shares.
06/06/19
SIDC
06/06/19
DOWNGRADE
Target $35
SIDC
Neutral
La-Z-Boy downgraded to Neutral from Buy at Sidoti
Sidoti analyst Anthony Lebiedzinski downgraded La-Z-Boy to Neutral from Buy and lowered his price target on the shares to $35 from $38 after the company pre-announced FY19 sales and earnings that were below consensus estimates. The Trump administration's threats for tariffs on goods imported from Mexico adds another layer of risk given La-Z-Boy's reliance on cut-and-sew kits from a Mexico facility and Joybird's manufacturing plant in Tijuana, Lebiedzinski said.

TODAY'S FREE FLY STORIES

APOG

Apogee Enterprises

$41.18

-0.38 (-0.91%)

06:34
09/17/19
09/17
06:34
09/17/19
06:34
Earnings
Apogee Enterprises reaffirms FY20 EPS view $3.00-$3.20, consensus $3.05 »

Reaffirms FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 23

    Sep

MDGL

Madrigal Pharmaceuticals

$99.50

4.89 (5.17%)

06:34
09/17/19
09/17
06:34
09/17/19
06:34
Recommendations
Madrigal Pharmaceuticals analyst commentary  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$0.00

(0.00%)

, UBER

Uber

$34.42

1.18 (3.55%)

06:32
09/17/19
09/17
06:32
09/17/19
06:32
Periodicals
SoftBank backers consider slashing committments to Vision Fund, Bloomberg says »

The biggest backers of…

SFTBF

SoftBank

$0.00

(0.00%)

UBER

Uber

$34.42

1.18 (3.55%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSI

Stage Stores

$0.85

0.0298 (3.63%)

06:32
09/17/19
09/17
06:32
09/17/19
06:32
Hot Stocks
Stage Stores announces plans to convert substantially all stores to off-price »

Stage Stores announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APOG

Apogee Enterprises

$41.18

-0.38 (-0.91%)

06:31
09/17/19
09/17
06:31
09/17/19
06:31
Earnings
Apogee Enterprises reports Q2 EPS 72, consensus 64c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 23

    Sep

IAC

IAC

$229.23

1.71 (0.75%)

06:30
09/17/19
09/17
06:30
09/17/19
06:30
Initiation
IAC initiated  »

IAC initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

AMRN

Amarin

$17.26

0.55 (3.29%)

, MDCO

The Medicines Co.

$48.74

0.99 (2.07%)

06:29
09/17/19
09/17
06:29
09/17/19
06:29
Recommendations
Citi puts Amarin and Sarepta on top five SMid cap biotech pick list »

Citi analyst Joel Beatty…

AMRN

Amarin

$17.26

0.55 (3.29%)

MDCO

The Medicines Co.

$48.74

0.99 (2.07%)

NERV

Minerva

$8.12

0.12 (1.50%)

SRPT

Sarepta

$87.02

1.01 (1.17%)

ELOX

Eloxx Pharmaceuticals

$6.45

0.1 (1.57%)

NGM

NGM Biopharmaceuticals

$15.85

-0.15 (-0.94%)

PTCT

PTC Therapeutics

$42.99

0.16 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MRVL

Marvell

$25.39

-0.46 (-1.78%)

06:28
09/17/19
09/17
06:28
09/17/19
06:28
Hot Stocks
SEC says Marvell Technology to pay $5.5M to settle disclosure-related charges »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$7.91

-0.075 (-0.94%)

, GOOG

Alphabet

$1,231.36

-8.24 (-0.66%)

06:28
09/17/19
09/17
06:28
09/17/19
06:28
Initiation
Angi Homeservices, Alphabet, Alphabet Class A initiated  »

Angi Homeservices…

ANGI

Angi Homeservices

$7.91

-0.075 (-0.94%)

GOOG

Alphabet

$1,231.36

-8.24 (-0.66%)

GOOGL

Alphabet Class A

$1,231.45

-8.68 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

MTCH

Match Group

$76.70

1.74 (2.32%)

06:26
09/17/19
09/17
06:26
09/17/19
06:26
Initiation
Match Group initiated  »

Match Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPL

LG Display

$6.42

-0.01 (-0.16%)

, AAPL

Apple

$219.88

1.17 (0.53%)

06:26
09/17/19
09/17
06:26
09/17/19
06:26
Periodicals
LG Display plans voluntary redundancy program, Reuters reports »

LG Display (LPL) plans to…

LPL

LG Display

$6.42

-0.01 (-0.16%)

AAPL

Apple

$219.88

1.17 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOLD

Barrick Gold

$17.11

-0.11 (-0.64%)

06:24
09/17/19
09/17
06:24
09/17/19
06:24
Hot Stocks
Barrick Gold says Acacia Mining scheme becomes effective »

On July 19, the Boards of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXRP

Lexaria Bioscience

$0.00

(0.00%)

06:22
09/17/19
09/17
06:22
09/17/19
06:22
Hot Stocks
Lexaria Bioscience says TurboCBD capsule study results published »

Lexaria Bioscience…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFNNY

Infineon

$0.00

(0.00%)

, SNPS

Synopsys

$133.17

-1.45 (-1.08%)

06:20
09/17/19
09/17
06:20
09/17/19
06:20
Hot Stocks
Infineon enters collaboration with Synopsys »

Infineon Technologies AG…

IFNNY

Infineon

$0.00

(0.00%)

SNPS

Synopsys

$133.17

-1.45 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

EADSY

Airbus

$0.00

(0.00%)

06:19
09/17/19
09/17
06:19
09/17/19
06:19
Periodicals
Airbus doesn't see major 2019 impact from tariffs, Reuters reports »

Possible U.S. tariffs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVER

EverQuote

$24.73

2.33 (10.40%)

06:18
09/17/19
09/17
06:18
09/17/19
06:18
Downgrade
EverQuote rating change  »

EverQuote downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$49.04

-0.45 (-0.91%)

06:15
09/17/19
09/17
06:15
09/17/19
06:15
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$48.74

0.99 (2.07%)

06:15
09/17/19
09/17
06:15
09/17/19
06:15
Downgrade
The Medicines Co. rating change  »

The Medicines Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBSDY

DBS Group

$0.00

(0.00%)

06:14
09/17/19
09/17
06:14
09/17/19
06:14
Downgrade
DBS Group rating change  »

DBS Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$300.20

-0.87 (-0.29%)

06:12
09/17/19
09/17
06:12
09/17/19
06:12
Periodicals
Trump says U.S., Japan reach initial trade agreement, NY Times reports »

President Trump says that…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$300.20

-0.87 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUNDF

Dream Global REIT

$0.00

(0.00%)

06:12
09/17/19
09/17
06:12
09/17/19
06:12
Downgrade
Dream Global REIT rating change  »

Dream Global REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$204.06

5.24 (2.64%)

06:12
09/17/19
09/17
06:12
09/17/19
06:12
Downgrade
Raytheon rating change  »

Raytheon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

ORTX

Orchard Therapeutics

$15.44

0.38 (2.52%)

06:10
09/17/19
09/17
06:10
09/17/19
06:10
Initiation
Orchard Therapeutics initiated  »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$59.95

-0.42 (-0.70%)

06:10
09/17/19
09/17
06:10
09/17/19
06:10
Hot Stocks
Sony rejects activist investor's call to spin off image sensor business »

Sony has rejected a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

XLRN

Acceleron

$44.67

0.75 (1.71%)

06:09
09/17/19
09/17
06:09
09/17/19
06:09
Recommendations
Acceleron analyst commentary  »

Acceleron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.